Skip to main content
Top
Published in: Journal of Diabetes & Metabolic Disorders 1/2020

01-06-2020 | Insulins | Research article

Culturally based pre-Ramadan education increased benefits and reduced hazards of Ramadan fasting for type 2 diabetic patients

Authors: Inass Shaltout, Abir Zakaria, Amr Mahmoud Abdelwahab, AbdelKhalek Hamed, Nehal Hamdy Elsaid, Mazen Ahmed Attia

Published in: Journal of Diabetes & Metabolic Disorders | Issue 1/2020

Login to get access

Abstract

Objectives

In the current study, we aimed at evaluating the effect of a culturally-based pre-Ramadan education program (PREP) on glycemic control, weight, adherence to post-sunset physical activity, perception of hypoglycemia, and anti-diabetic medication dose adjustment during Ramadan fasting in type 2 diabetics.

Study design

A total of 1008 type 2 Diabetes patients were offered a culturally-based PREP in addition to the standard of care, two months before Ramadan. A retrospective interview one month after Ramadan compared the fasting experience of PREP attendees (470 patients) with those who merely received standard of care (538 patients) (Non-PREP).

Results

Ramadan fasting improved glycemic control with a correlation between HbA1c percent reduction and the number of fasting days (r = −0.290, p = 0.007). More HbA1c and weight percent reduction were observed in PREP attendees compared to the Non-PREP group (−14.8% ± 9.3 vs. -5.4% ± 5.4; p < 0.001; and − 1.96% ± 5.4 vs. -0.39% ± 2.8; p < 0.001, respectively). More commitment to night prayers in the PREP attendees compared to the Non-PREP group, (85.5% prayed >20 nights vs 28.4%; p < 0.001) with more HbA1c and weight percent reduction in the those who performed the prayers more than 20 nights compared to those who performed no prayers (−11.69% ± 8.8 vs −6.28% ± 6.4, p < 0.001; and − 2.76% ±5.1 vs 1.35% ±1.8, p < 0.001, respectively). More perception of true hypoglycemia was associated with PREP attendance (p0.046), insulin treatment (p0.000), and reduction of antidiabetic medication dosage (p0.004). Repeated lowering of antidiabetic medications doses with sequential downsizing of meals’ portions, and appetite was reported.

Conclusion

Ramadan fasting was beneficial for people with type 2 diabetes with reduction of HbA1c in correlation with the number of fasting days. Contrasting PREP with Non-PREP participants discovered better HbA1c and weight reduction in the former group even with equal number of fasting days. PREP participants performed more Taraweeh night prayers. The more the prayer nights the more decline of HbA1c and weight was observed. PREP improved perception and response to hypoglycemia with low-dosing of antidiabetic medications, especially insulin.
Appendix
Available only for authorised users
Literature
2.
go back to reference Zakaria A, Sabry I, El Shehaby A. Ramadan-like fasting reduces carbonyl stress and improves Glycemic control in insulin treated type 2 diabetes mellitus patients. Life science Journal. 2013;10(2):384–90. Zakaria A, Sabry I, El Shehaby A. Ramadan-like fasting reduces carbonyl stress and improves Glycemic control in insulin treated type 2 diabetes mellitus patients. Life science Journal. 2013;10(2):384–90.
8.
go back to reference Hassanein M. Ramadan focused diabetes education; a much needed approach. J Pak Med Assoc. 2015 May;65(5 Suppl 1):S76–8.PubMed Hassanein M. Ramadan focused diabetes education; a much needed approach. J Pak Med Assoc. 2015 May;65(5 Suppl 1):S76–8.PubMed
9.
go back to reference Hassan A, Meo SA, Usmani AM, Shaikh TJ. Diabetes during Ramadan – PRE-approach model: presentation, risk stratification, education. Eur Rev Med Pharmacol Sci. 2014;18:1798–805.PubMed Hassan A, Meo SA, Usmani AM, Shaikh TJ. Diabetes during Ramadan – PRE-approach model: presentation, risk stratification, education. Eur Rev Med Pharmacol Sci. 2014;18:1798–805.PubMed
11.
go back to reference Eid Y M, Sahmoud S I, Abdelsalam M M, and Eichorst B. Empowerment-Based Diabetes Self-Management Education to Maintain Glycemic Targets During Ramadan Fasting in People With Diabetes Who Are on Conventional Insulin: A Feasibility Study. Spectrum.Diabetesjournals.org. 2017, 30 (1): 36–42. Eid Y M, Sahmoud S I, Abdelsalam M M, and Eichorst B. Empowerment-Based Diabetes Self-Management Education to Maintain Glycemic Targets During Ramadan Fasting in People With Diabetes Who Are on Conventional Insulin: A Feasibility Study. Spectrum.Diabetesjournals.org. 2017, 30 (1): 36–42.
12.
go back to reference Zainudin SB, Abu Bakar KNB, Abdullah SB, Hussain AB. Diabetes education and medication adjustment in Ramadan (DEAR) program prepares for self-management during fasting with tele-health support from pre-Ramadan to post-Ramadan. Ther Adv Endocrinol Metab. 2018;9(8):231–40.CrossRef Zainudin SB, Abu Bakar KNB, Abdullah SB, Hussain AB. Diabetes education and medication adjustment in Ramadan (DEAR) program prepares for self-management during fasting with tele-health support from pre-Ramadan to post-Ramadan. Ther Adv Endocrinol Metab. 2018;9(8):231–40.CrossRef
14.
go back to reference Ibrahim M, Abu Al Magd M, Annabi FA, Assaad-Khalil S, Ba-Essa EM, Fahdil I, et al. Recommendations for management of diabetes during Ramadan: update 2015. BMJ Open Diabet Res Care. 2015;3(1):e000108.CrossRef Ibrahim M, Abu Al Magd M, Annabi FA, Assaad-Khalil S, Ba-Essa EM, Fahdil I, et al. Recommendations for management of diabetes during Ramadan: update 2015. BMJ Open Diabet Res Care. 2015;3(1):e000108.CrossRef
15.
go back to reference Saudek CD, Brick JC. Clinical advances in Hemoglobin A1c measurement. The clinical use of Hemoglobin A1c. J Diabetes Sci Technol. 2009;3(4):629–34.CrossRef Saudek CD, Brick JC. Clinical advances in Hemoglobin A1c measurement. The clinical use of Hemoglobin A1c. J Diabetes Sci Technol. 2009;3(4):629–34.CrossRef
16.
go back to reference Pivovarov R, Albers DJ, Hripcsak G, Sepulveda JL, Elhadad N. Temporal trends of hemoglobin A1c testing. J Am Med Inform Assoc. 2014;21(6):1038–44.CrossRef Pivovarov R, Albers DJ, Hripcsak G, Sepulveda JL, Elhadad N. Temporal trends of hemoglobin A1c testing. J Am Med Inform Assoc. 2014;21(6):1038–44.CrossRef
17.
go back to reference Siaw M Y L, Chew D EK, Dalan R, Abdul Shakoor S AK K, Othman N, Choo CH, Shamsuri NH, Abdul Karim SN, Chan SY, Lee J Y. Evaluating the Effect of Ramadan Fasting on Muslim Patients with Diabetes in relation to Use of Medication and Lifestyle Patterns: A Prospective Study. International Journal of Endocrinology. 2014, Article ID 308546, 6 pages. doi: 10.1155/2014/308546. Siaw M Y L, Chew D EK, Dalan R, Abdul Shakoor S AK K, Othman N, Choo CH, Shamsuri NH, Abdul Karim SN, Chan SY, Lee J Y. Evaluating the Effect of Ramadan Fasting on Muslim Patients with Diabetes in relation to Use of Medication and Lifestyle Patterns: A Prospective Study. International Journal of Endocrinology. 2014, Article ID 308546, 6 pages. doi: 10.1155/2014/308546.
18.
go back to reference Gaborit B, Dutour O, Ronsin O, Atlan C, Darmon P, Gharsalli R, et al. Diabetes &Metabolism. Ramadan fasting with diabetes: an interview study of inpatients’ and general practitioners’ attitudes in the south of France. Diabète et jeûne du Ramadan: regards croisés patients et médecinsgénéralistesdans le Sud de la France. Diabetes Metab. 2011;37:395–402.CrossRef Gaborit B, Dutour O, Ronsin O, Atlan C, Darmon P, Gharsalli R, et al. Diabetes &Metabolism. Ramadan fasting with diabetes: an interview study of inpatients’ and general practitioners’ attitudes in the south of France. Diabète et jeûne du Ramadan: regards croisés patients et médecinsgénéralistesdans le Sud de la France. Diabetes Metab. 2011;37:395–402.CrossRef
20.
go back to reference Norouzy A, Mohajeri SM, Shakeri S, Yari F, Sabery M, Philippou E, et al. Effect of Ramadan fasting on glycemic control in patients with type 2 diabetes. J Endocrinol Investig. 2012;35(8):766–71. Norouzy A, Mohajeri SM, Shakeri S, Yari F, Sabery M, Philippou E, et al. Effect of Ramadan fasting on glycemic control in patients with type 2 diabetes. J Endocrinol Investig. 2012;35(8):766–71.
21.
go back to reference Zainudin SB, Ang D Y and Soh AWE. Knowledge of diabetes mellitus and safe practices during Ramadan fasting among Muslim patients with diabetes mellitus in Singapore Singapore Med J. 2017; 58(5): 246–252. doi: 10.11622/smedj.2016085 Zainudin SB, Ang D Y and Soh AWE. Knowledge of diabetes mellitus and safe practices during Ramadan fasting among Muslim patients with diabetes mellitus in Singapore Singapore Med J. 2017; 58(5): 246–252. doi: 10.11622/smedj.2016085
25.
go back to reference Monnier L, Lapinski H, Colette C. Contributions of fasting and postprandial plasma glucose increments to the overall diurnal hyperglycemia of type 2 diabetic patients: variations with increasing levels of HbA(1c). Diabetes Care. 2003;26(3):881–5.CrossRef Monnier L, Lapinski H, Colette C. Contributions of fasting and postprandial plasma glucose increments to the overall diurnal hyperglycemia of type 2 diabetic patients: variations with increasing levels of HbA(1c). Diabetes Care. 2003;26(3):881–5.CrossRef
26.
go back to reference Monnier L, Colette C, and Owens D R. Glycemic Variability: The Third Component of the Dysglycemia in Diabetes. Is It Important? How to Measure It? Journal of Diabetes Science and Technology. 2008; 2 (6). Monnier L, Colette C, and Owens D R. Glycemic Variability: The Third Component of the Dysglycemia in Diabetes. Is It Important? How to Measure It? Journal of Diabetes Science and Technology. 2008; 2 (6).
27.
go back to reference Salti I, , Bénard E, Detournay B, Bianchi-Biscay M, Le Brigand C, Voinet C, Abdul Jabbar, and on behalf of the EPIDIAR study group. A population-based study of diabetes and its characteristics during the fasting month of Ramadan in 13 countries. Results of the epidemiology of diabetes and Ramadan 1422/2001 (EPIDIAR) study. Diabetes Care 2004; 27(10): 2306–2311. doi: https://doi.org/10.2337/diacare.27.10.2306.CrossRefPubMed Salti I, , Bénard E, Detournay B, Bianchi-Biscay M, Le Brigand C, Voinet C, Abdul Jabbar, and on behalf of the EPIDIAR study group. A population-based study of diabetes and its characteristics during the fasting month of Ramadan in 13 countries. Results of the epidemiology of diabetes and Ramadan 1422/2001 (EPIDIAR) study. Diabetes Care 2004; 27(10): 2306–2311. doi: https://​doi.​org/​10.​2337/​diacare.​27.​10.​2306.CrossRefPubMed
28.
go back to reference Loke SC, Rahim KF, Kanesvaran R, Wong TW. A prospective cohort study on the effect of various risk factors on hypoglycaemia in diabetics who fast during Ramadan. Med J Malaysia. 2010 Mar;65(1):3–6.PubMed Loke SC, Rahim KF, Kanesvaran R, Wong TW. A prospective cohort study on the effect of various risk factors on hypoglycaemia in diabetics who fast during Ramadan. Med J Malaysia. 2010 Mar;65(1):3–6.PubMed
30.
go back to reference Hassanein M, Al-Arouj M, Hamdy O, Bebakar WMW, Jabbar A, Al-Madani A, Hanif W, Lessan N, Basit A, Tayeb K, Omar M, Abdallah K, Al Twaim A, Buyukbese MA, El-Sayed AA, Ben-Nakhi A; International Diabetes Federation (IDF), in collaboration with the Diabetes and Ramadan (DAR) International Alliance. Diabetes and Ramadan: Practical guidelines. Diabetes Res ClinPract. 2017; 126: 303-316. https://doi.org/10.1016/j.diabres.2017.03.003. Hassanein M, Al-Arouj M, Hamdy O, Bebakar WMW, Jabbar A, Al-Madani A, Hanif W, Lessan N, Basit A, Tayeb K, Omar M, Abdallah K, Al Twaim A, Buyukbese MA, El-Sayed AA, Ben-Nakhi A; International Diabetes Federation (IDF), in collaboration with the Diabetes and Ramadan (DAR) International Alliance. Diabetes and Ramadan: Practical guidelines. Diabetes Res ClinPract. 2017; 126: 303-316. https://​doi.​org/​10.​1016/​j.​diabres.​2017.​03.​003.
32.
go back to reference Cheng AYY, Fantus IG. Oral antihyperglycemic therapy for type 2 diabetes mellitus. CMAJ. 2005;172(2):213–26.CrossRef Cheng AYY, Fantus IG. Oral antihyperglycemic therapy for type 2 diabetes mellitus. CMAJ. 2005;172(2):213–26.CrossRef
34.
go back to reference Horton TJ, Hill JO. Prolonged fasting significantly changes nutrient oxidation and glucose tolerance after a normal mixed meal. J ApplPhysiol. 2001;90(1):155–63. Horton TJ, Hill JO. Prolonged fasting significantly changes nutrient oxidation and glucose tolerance after a normal mixed meal. J ApplPhysiol. 2001;90(1):155–63.
38.
go back to reference Adam TC, Tsao S, Page KA, Hu H, Hasson RE, Goran MI. Insulin sensitivity and brain reward activation in overweight Hispanic girls: a pilot study. PediatrObes. 2015;10(1):30–6. Adam TC, Tsao S, Page KA, Hu H, Hasson RE, Goran MI. Insulin sensitivity and brain reward activation in overweight Hispanic girls: a pilot study. PediatrObes. 2015;10(1):30–6.
39.
go back to reference Ryan RM, Deci EL. On happiness and human potentials: a review of research on hedonic and Eudaimonic well-being. Annu Rev Psychol. 2001;52:141–66.CrossRef Ryan RM, Deci EL. On happiness and human potentials: a review of research on hedonic and Eudaimonic well-being. Annu Rev Psychol. 2001;52:141–66.CrossRef
40.
go back to reference Ashby FG, Isena M, Turken U. A neuropsychological theory of positive affect and its influence on cognition. Psychol Rev. 1999;106(3):529–50.CrossRef Ashby FG, Isena M, Turken U. A neuropsychological theory of positive affect and its influence on cognition. Psychol Rev. 1999;106(3):529–50.CrossRef
Metadata
Title
Culturally based pre-Ramadan education increased benefits and reduced hazards of Ramadan fasting for type 2 diabetic patients
Authors
Inass Shaltout
Abir Zakaria
Amr Mahmoud Abdelwahab
AbdelKhalek Hamed
Nehal Hamdy Elsaid
Mazen Ahmed Attia
Publication date
01-06-2020
Publisher
Springer International Publishing
Published in
Journal of Diabetes & Metabolic Disorders / Issue 1/2020
Electronic ISSN: 2251-6581
DOI
https://doi.org/10.1007/s40200-020-00489-1

Other articles of this Issue 1/2020

Journal of Diabetes & Metabolic Disorders 1/2020 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.